introduction to clinical research and research questions thomas b. newman, md,mph professor of...
TRANSCRIPT
![Page 1: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/1.jpg)
Introduction to Clinical Research and Research
Questions
Thomas B. Newman, MD,MPH
Professor of Epidemiology & Biostatistics and Pediatrics, UCSF
Epi 150.03, August 2, 2009
![Page 2: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/2.jpg)
Outline
Anatomy and Physiology of Research
Research questions Examples
![Page 3: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/3.jpg)
Anatomy of research: What it’s made of
Research question, significance Study design Study subjects and how they will
be sampled Variables and how they will be
measured– Predictor – Outcome
Analysis plan, sample size calculation
![Page 4: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/4.jpg)
Highly Recommended
![Page 5: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/5.jpg)
NIH Roadmap Initiative-translating discoveries into health
Westfall JM et al, JAMA 2007
![Page 6: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/6.jpg)
Translational Research and Studies for Epi 150.03 Not the best choice for this course
– Animals, molecules without humans– Data syntheses, e.g. decision analysis,
cost-effectiveness analysis, meta-analysis
– Qualitative research
Ideal– A new observational study or clinical trial
involving humans that you could do (or at least start) this year
![Page 7: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/7.jpg)
What if I am doing a secondary data analysis? You can: Use it for your DCR project, rethinking
decisions that were already made and getting thoughts and suggestions for colleagues
Design a new study you aren’t (currently) planning to do
![Page 8: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/8.jpg)
Physiology of research: How it works
Using measurements in a sample to draw inferences about phenomena in a population
![Page 9: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/9.jpg)
DCR Figure 1.3
![Page 10: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/10.jpg)
DCR Figure 1.4
![Page 11: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/11.jpg)
DCR Figure 1.5
![Page 12: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/12.jpg)
Do I really have to do all of those laboratory tests before I can start phototherapy in jaundiced babies?
LEJN = Laboratory Evaluation of Jaundice in Newborns
Newman research question #1
![Page 13: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/13.jpg)
Digression: the importance of a good acronym Fun to create Gives your study credibility and life Favorite examples:
– Multiple Risk Factor Intervention Trial = MRFIT
– Jim Kahn’s study: Gestational Diabetes Formulas for Cost-Effectiveness
GeDi FORCE
![Page 14: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/14.jpg)
Background for Question #1 Bilirubin: Yellow
breakdown product of heme (from red blood cells)
Jaundice: Yellow color of whites of eyes and skin due to high bilirubin. Usually indicates liver or blood disease, but generally is normal in newborns
![Page 15: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/15.jpg)
Background to Question #1, cont’d
Phototherapy: Shining light on the babies skin -- helps lower bilirubin levels
Very high bilirubin levels can cause kernicterus (brain damage)
![Page 16: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/16.jpg)
Background to Question #1, cont’d A complete "hyperbilirubinemia work-
up" used to be recommended for significant jaundice:– Total and direct bilirubin– Direct and indirect Coombs’ tests– Complete Blood Count– Blood smear for red cell morphology– Reticulocyte count– Urine reducing substance
![Page 17: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/17.jpg)
Background to Question #1, cont’d In TN’s experience reference ranges
were poorly defined and results rarely if ever affected management
As a pediatric resident TN did not like having to get out of bed to draw blood for these tests before being allowed to start phototherapy
![Page 18: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/18.jpg)
Background: International Comparison of Spending on Health, 1980–2006
0
1000
2000
3000
4000
5000
6000
7000
1980 1984 1988 1992 1996 2000 2004
AustraliaCanadaDenmarkFranceGermanyNetherlandsNew ZealandSwedenSwitzerlandUnited KingdomUnited States
Average spending on healthper capita ($US PPP)
0
2
4
6
8
10
12
14
16
1980 1984 1988 1992 1996 2000 2004
AustraliaCanadaDenmarkFranceGermanyNetherlandsNew ZealandSwedenSwitzerlandUnited KingdomUnited States
Total expenditures on healthas percent of GDP
Data: OECD Health Data 2008 (June 2008). From Commonwealth fund
TN concerned about costs
![Page 19: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/19.jpg)
More refined research question #1
(i.e., what we really want to know) Do the expected health benefits of the
recommended tests justify their costs?– Subjects: Jaundiced newborns (candidates
for phototherapy)– Predictor variable: obtaining the tests– Outcome variable: measurements of health
and costs
![Page 20: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/20.jpg)
Laboratory Evaluation of Jaundice in Newborns (LEJN) study questions
(i.e., questions our study can answer) How often are each of these tests done
in newborns at UCSF and Stanford? How often are they abnormal? When they are abnormal what
diagnoses are made as a result of the test?
In what proportion is treatment altered? Diagnostic yield study (Chapter 12)
![Page 21: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/21.jpg)
Compromises Just 2 S.F. Bay Area teaching hospitals Surrogate outcome:
– Discharge diagnosis of a significant disease– Diagnosed after an abnormal jaundice work-up
Retrospective study– Limited to those in whom MD ordered the tests,
rather than those with a certain level of jaundice or meeting other inclusion criteria
– No control over how tests were done
![Page 22: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/22.jpg)
Design and ImplementationTRUTH IN THE UNIVERSE TRUTH IN THE STUDY FINDINGS IN THE STUDY
Research Question Study Plan Actual studyShould I do test? What is yield of test? What does yield look like
from my database and chart review?
Jaundiced term newborns Jaundiced newborns ≥ 37 weeks (by obstetrician estimate) born at UCSF and Stanford 1986-7
Newborns ≥ 37 weeks who had the test and have test results included in the COPE database
Health benefit of testing Yield of testing Discharge diagnoses of signficant diseases made after an abnormal test result (based on electronic discharge abstracts and chart review)
![Page 23: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/23.jpg)
Is RQ FINER?
Feasible
Interesting
Novel
Ethical
Relevant
![Page 24: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/24.jpg)
Can you put your FINGER on a good research question
Feasible
Interesting
Novel
Good for your career
Ethical
Relevant
![Page 25: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/25.jpg)
Good for your career
Try to identify a research question that will allow you to– Learn more about an area of potential
long-term interest– Acquire new skills you could use on other
projects– Work with people and/or organizations with
whom you want to develop a long term relationship
– Build on the project for future work
![Page 26: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/26.jpg)
Special considerations for Students and Residents Are the people nice to work with? Can you finish something? Can you contribute enough to be a
coauthor? Do you understand and believe in the
importance of the question you will address?
![Page 27: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/27.jpg)
LEJN: Direct Bilirubin Results -1 Test ordered 15 times as often per infant at
UCSF as at Stanford Results more than twice as high
1 2 3 4 5 6 7 ≥ 8mg/dL
AJDC 1991;145:1305-1309
![Page 28: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/28.jpg)
LEJN Results: Direct Bilirubin Results -2AJDC 1991;145:1305-09
Spontaneous resolution in all 4 infants
![Page 29: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/29.jpg)
LEJN Conclusions
“Because of their low yield and poor specificity, direct bilirubin tests are seldom helpful in evaluating jaundice in term newborns.”
AJDC 1991;145:1305-1309
![Page 30: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/30.jpg)
August 6 is Hiroshima Day (65 years)
![Page 31: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/31.jpg)
Do I really have to do all of those laboratory tests and admit infants < 3 months old with fevers?
Newman research question #2
![Page 32: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/32.jpg)
Background to Question #2 A complete sepsis work-up and IV antibiotics
used to be “required” for all infants < 3 months old with fevers at academic medical centers– Complete Blood Count and blood culture– Urinalysis and urine culture– Lumbar puncture and CSF culture– Hospital admission for 2-3 days of IV antibiotics
Many practicing pediatricians were skeptical of this requirement
PROS (Pediatric Research in Office Settings) is the American Academy of Pediatrics research network
![Page 33: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/33.jpg)
Study questions for the PROS Febrile Infant Study (FIS) How do practicing pediatricians manage
young febrile infants? What variables predict testing and
positive tests? What is the outcome of infants not
initially tested? TN piece: urine tests
![Page 34: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/34.jpg)
PROS FIS Design considerations Subjects
– Infants < 3 months old with T > 38.0 seen by a Pediatric Research in Office Settings (PROS) practitioner
– Issues• Different from infants presenting
to inner city emergency rooms• PROS practitioners may not be
representative• Not all eligible infants enrolled
![Page 35: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/35.jpg)
PROS FIS Design considerations -2
Cross-sectional study– Prevalence & predictors of urine testing at
first visit– Prevalence & predictors of Urinary Tract
Infection (UTI) among those tested Cohort study
– Begin with measurements made at baseline
– Follow the infants to see what happens to them, especially those not initially treated
![Page 36: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/36.jpg)
PROS FIS Design considerations -3
Predictors – Physician characteristics, results of history,
& physical examination, treatments Both predictor and outcome
– Whether or not urine tests done– How urine tests done
Outcome variables – Positive urine culture at initial visit (UTI)– Recovery from the acute febrile illness– Late diagnosis of UTI
![Page 37: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/37.jpg)
The same study can answer multiple research questions Designation of predictor and outcome
variables depends on the research questions
Maintain clarity on the research question or it can get confusing
![Page 38: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/38.jpg)
PROS FIS Selected Results Only 54% of infants had urine tested at the
initial visit 10% of those tested at the initial visit had a
urinary tract infection (UTI) Uncircumcised boys were >10 times as likely
to have a UTI but no more likely to have urine tested
Other risk factors for UTI also predicted testing, e.g.,– Height of fever– Lack of viral symptoms– Lack of sick family members
![Page 39: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/39.jpg)
What happened to those not tested? N= 1400 who had no urine test first visit
– N = 1324 followed-up through end of illness• N= 807 not initially treated with
antibiotics–2 (0.25%) were diagnosed with UTI
the next day–Both received antibiotics and did well
• N= 805 illnesses resolved without diagnosis of UTI
![Page 40: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/40.jpg)
Why were there so few late diagnoses of UTI in those not initially tested?
Those not tested were at very low risk Most UTIs in infants resolve spontaneously Based on levels of risk factors in those not
tested, 61 UTIs were expected in that group Since only 2 were observed, either most UTIs
resolve spontaneously or the PROS practitioners were using some secret extremely effective method for selecting infants for urine testing
![Page 41: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/41.jpg)
Alan Schroeder’s Research Questions:
What methods do practitioners use to obtain urine samples in young febrile infants?
What are predictors of using invasive methods (catheterization or bladder tap)?
How do different methods compare– Urine culture results– Correlation between UA and culture
Schroeder AR, Newman TB, Wasserman RC, Finch SA, Pantell RH. Choice of urine collection methods for the diagnosis of urinary tract infection in young, febrile infants. Arch Pediatr Adolesc Med. 2005 Oct;159(10):915-22, 2005
![Page 42: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/42.jpg)
Next …
![Page 43: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/43.jpg)
One sentence describing anatomy of your study
Design Variables
– Predictor– Outcome
Subjects
![Page 44: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/44.jpg)
Examples This is a randomized double-blind trial to see
whether low doses of oral diphenydramine reduce self-reported severity of motion sickness among elderly passengers on a cruise ship.
This is a prospective cohort study to estimate the effects of various medical treatments for osteoarthritis on the risk of intensive care unit admission for H1N1 influenza among members of the Northern California Kaiser Permanente Medical Care Program
![Page 45: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/45.jpg)
Do you have a FINERG research question?
Feasible
Interesting
Novel
Ethical
Relevant
Good for your career
![Page 46: Introduction to Clinical Research and Research Questions Thomas B. Newman, MD,MPH Professor of Epidemiology & Biostatistics and Pediatrics, UCSF Epi 150.03,](https://reader035.vdocuments.site/reader035/viewer/2022062422/56649e6a5503460f94b673c5/html5/thumbnails/46.jpg)
Questions and comments